Related Experiment Videos

Relationship between free T4 levels and postnatal steroid therapy in preterm infants

Hirokazu Arai1, Ryoji Goto, Takefumi Matsuda

  • 1Department of Pediatrics, Akita Red Cross Hospital, Akita, Japan. arahiro@med.akita-u.ac.jp

Pediatrics International : Official Journal of the Japan Pediatric Society
|May 8, 2009
PubMed

Insights

Postnatal steroid therapy in preterm infants is associated with lower thyroid hormone levels. Steroid treatment in premature infants may impact thyroid function, requiring further investigation into its long-term effects.

Area of Science:

  • Neonatal endocrinology
  • Pediatric critical care

Background:

  • Transient hypothyroxinemia is common in preterm infants due to immaturity and illness.
  • Thyroid hormone status in premature infants is influenced by various factors.

Purpose of the Study:

  • To investigate the relationship between early postnatal steroid therapy and thyroid hormone status.
  • To assess the impact of dexamethasone on free thyroxine (FT4) and thyroid-stimulating hormone (TSH) levels in preterm infants.

Main Methods:

  • Prospective study of infants born before 28 weeks gestation.
  • Comparison of thyroid hormone levels (FT4, TSH) at 2 weeks in infants receiving (n=8) versus not receiving (n=73) postnatal dexamethasone.
  • Dexamethasone was administered for lung disease management.

Main Results:

  • Infants receiving steroids showed significantly lower FT4 and TSH levels at 2 weeks.
  • FT4 levels increased more after steroid withdrawal compared to controls.
  • No significant demographic or illness differences between groups.

Conclusions:

  • Postnatal steroid treatment appears to reduce FT4 and TSH levels in very preterm infants.
  • Non-thyroidal illness may also contribute to reduced thyroid hormone levels.
  • Further research is needed to understand the clinical implications of steroid-induced thyroid changes.
Abstract

Related Concept Videos

Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Functions of Thyroid Hormones01:18

Functions of Thyroid Hormones

The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when researchers try to extrapolate results...